Lorenzo Razzolini

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.

Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 19, 2025

Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Journal: Journal of neurology

Published: September 04, 2024

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project.

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project.

Journal: Neurology and therapy

Published: April 19, 2024

Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Journal: Journal of neurology

Published: March 25, 2024

Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.

Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.

Journal: Journal of neurology

Published: November 30, 2023

Multiple Sclerosis Progression and Relapse Activity in Children.

Multiple Sclerosis Progression and Relapse Activity in Children.

Journal: JAMA neurology

Published: November 27, 2023

Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.

Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.

Journal: JAMA neurology

Published: July 25, 2022

Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area.

Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area.

Journal: International journal of environmental research and public health

Published: May 17, 2022

Sleep profile in a population of community-dwelling nonagenarians: data from the Mugello study.

Sleep profile in a population of community-dwelling nonagenarians: data from the Mugello study.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: May 12, 2022

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies.

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 30, 2022

Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.

Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 17, 2022

Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.

Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.

Journal: Brain : a journal of neurology

Published: October 16, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026